Table 5.
Effect of medium-chain-triglyceride on growth performance of weanling pigs (Exp. 2)1
| Items | NC | PC | MCT3 | MCT5 | SE2 |
|---|---|---|---|---|---|
| 0 to 14 d (phase 1) | |||||
| ADG (g) | 490ab | 476b | 517ab | 521a | 14 |
| ADFI (g) | 609 | 620 | 628 | 661 | 21 |
| F/G | 1.243 | 1.303 | 1.215 | 1.269 | 0.046 |
| 15 to 35 d (phase 2) | |||||
| ADG (g) | 625 | 636 | 635 | 641 | 13 |
| ADFI (g) | 1,095a | 1,000b | 1,043ab | 1,045ab | 27 |
| F/G | 1.752a | 1.572b | 1.643ab | 1.630ab | 0.04 |
| 0 to 35 d (Overall phase) | |||||
| ADG (g) | 571 | 572 | 590 | 593 | 8 |
| ADFI (g) | 901 | 848 | 877 | 891 | 19 |
| F/G | 1.578 | 1.483 | 1.486 | 1.503 | 0.031 |
a,b
Within a row, mean with different superscripts differ (p<0.05).
1
Each mean represents 6 pens with 5 pigs each per treatment. Dietary treatments were as follows: NC = Negative control diet; PC = Positive control diet with 40 mg/kg Tiamulin, 110 mg/kg Tylosin, and 10 mg/kg Enramycin. MCT3 = NC+0.32% medium-chain-triglyceride. MCT5 = NC+0.55% (phase 1), 0.32% (phase 2, 3) medium-chain-triglyceride.
2
Standard errors.